Evidence map›Paper›PMID 38597610›Full record

ArticleNucleic acids research2024

NetActivity enhances transcriptional signals by combining gene expression into robust gene set activity scores through interpretable autoencoders.

Carlos Ruiz-Arenas, Irene Marín-Goñi, Liewei Wang, Idoia Ochoa, Luis A Pérez-Jurado, Mikel Hernaez

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Carlos Ruiz-ArenasComputational Biology Program, CIMA University of Navarra, idiSNA, Pamplona 31008, Spain.ORCID 0000-0002-6014-3498
Irene Marín-GoñiComputational Biology Program, CIMA University of Navarra, idiSNA, Pamplona 31008, Spain.ORCID 0000-0002-5060-0712
Liewei WangDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Idoia OchoaDepartment of Electrical and Electronics Engineering, Tecnun, University of Navarra, Donostia, Spain.ORCID 0000-0003-1864-7868
Luis A Pérez-JuradoDepartment MELIS, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Mikel HernaezComputational Biology Program, CIMA University of Navarra, idiSNA, Pamplona 31008, Spain.ORCID 0000-0003-0443-2305
Mayo Clinic · USUniversidad de Navarra · ESUniversitat Pompeu Fabra · ES

Funding

Ayudas Predoctorales Gobierno de Navarra 0011-0537-2021-000106Congressionally Directed Medical Research ProgramsDepartment of Defense W81XWH-20-1-0262European UnionNextGenerationEU/PRTR PID2020-114394RA-C33Gipuzkoa Fellows 2022-FELL-000003-01Mayo Clinic Center for Individualized Medicine MC1351Scientific Foundation of the Spanish Association Against Cancer POSTD235059RUIZ
6 · The paper itself

Abstract

Grouping gene expression into gene set activity scores (GSAS) provides better biological insights than studying individual genes. However, existing gene set projection methods cannot return representative, robust, and interpretable GSAS. We developed NetActivity, a machine learning framework that generates GSAS based on a sparsely-connected autoencoder, where each neuron in the inner layer represents a gene set. We proposed a three-tier training that yielded representative, robust, and interpretable GSAS. NetActivity model was trained with 1518 GO biological processes terms and KEGG pathways and all GTEx samples. NetActivity generates GSAS robust to the initialization parameters and representative of the original transcriptome, and assigned higher importance to more biologically relevant genes. Moreover, NetActivity returns GSAS with a more consistent definition and higher interpretability than GSVA and hipathia, state-of-the-art gene set projection methods. Finally, NetActivity enables combining bulk RNA-seq and microarray datasets in a meta-analysis of prostate cancer progression, highlighting gene sets related to cell division, key for disease progression. When applied to metastatic prostate cancer, gene sets associated with cancer progression were also altered due to drug resistance, while a classical enrichment analysis identified gene sets irrelevant to the phenotype. NetActivity is publicly available in Bioconductor and GitHub.

Indexed as

Prostatic NeoplasmsAlgorithmsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMachine LearningMaleRNA-SeqTranscriptome

Identifiers

PMID38597610
PMCPMC11109970
OpenAlexW4394694792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.